The Glucuronolactone Market size is projected to be valued at USD 120 million in 2023 and is expected to rise to USD 256.2 million by 2033. The sales of glucuronolactone are expected to thrive at a significant CAGR of 8.0% during the forecast period.
Glucuronolactone is used as a food additive in food and functional beverages. In terms of purity, 0.99% grade of glucuronolactone is highly preferable among manufacturers. Also, increasing consumption of energy drinks is one of the key factors fueling the demand for Glucuronolactone in the market.
Glucuronolactone is an odorless, white solid substance found in people, animals, and the gums of plants. It is a vital component of all linked tissues. It is a chemical created by the human liver's glucose metabolism. Glucuronolactone is a component of connective tissues as well as an important antioxidant in the production of ascorbic acid.
Given its numerous health benefits, the increasing adoption of glucuronolactone from various end-use industries such as pharmaceuticals and food and beverages is a significant factor contributing to the growth glucuronolactone market. Some factors expected to drive the glucuronolactone market further during the forecast period include:
| Attributes | Details |
|---|---|
| Glucuronolactone Market Estimated Size (2023) | USD 120 million |
| Glucuronolactone Market CAGR (2023 to 2033) | 8.0% |
| Glucuronolactone Market Forecasted Size (2033) | USD 256.2 million |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Glucuronolactone sales expanded at a CAGR of 5.4% between 2018 and 2022. The period marked the entry of various market players and product innovations.
In pharmaceuticals, glucuronolactone is frequently used as a component in the production of a range of treatment options for food and drug poisoning, hepatitis, and immune response modulation. Further, a rise in demand from bodybuilders and athletes is also expected to contribute to market expansion.
High glucuronolactone prices, as well as various negative impacts related to excessive glucuronolactone intakes, such as dizziness, disorientation, and fast heartbeat, are anticipated to hamper the market growth during the forecast period.
The human brain, liver, and heart contain glucuronolactone, which is involved in a range of physiological functions. Some of its metabolic roles include osmoregulation, membrane stability, and bile acid conjugation. Further, cardiovascular disease, retinal degeneration, and epilepsy are all diseases that can be caused by glucuronolactone shortage.
Glucuronolactone supplementation has been demonstrated to be beneficial to one's health. This indeed is increasing the demand for dietary supplements around the world as people grow concerned about their health. Furthermore, this has increased demand for glucuronolactone containing supplements, resulting in market expansion.
The rise in demand from the pharmaceutical and food & beverage industries, as well as increased awareness about a healthy lifestyle, are two key factors driving the glucuronolactone market.
The pharmaceutical application is estimated to rise at a signifcant rate, with a CAGR of 7.0% from 2023 to 2033, as a result of the increased application of glucuronolactone-based pills and supplements to treat hepatocirrhosis, arthritis, and hepatitis, Furthermore, the market growth is likely to be fueled by the recovery of the pharmaceutical industry in the United States over the forecast period.
The powder form of glucuronolactone is projected to account for a significant share as consumers are consuming it as a dietary supplement over the projection period. Additionally, a growing health conscious population in the urban area is expected to boost demand growth for powder glucuronolactone.
The United States accounted for 25.7% of the total market in 2022 in North America and is expected to rise significantly due to the widespread use of glucuronolactone as a nutritional supplement in the country. Additionally, glucuronolactone-containing drinks have been popular in the country.
Companies like Rockstar Inc., Red Bull, and Monster have released numerous glucuronolactone-containing drinks, which might offer enormous potential throughout the projected period. However, due to restrictions on the use of glucuronolactone in traditional beverages, the majority of these drinks are sold as supplements.
The use of glucuronolactone in prescription medications for the treatment of collagen disease, hepatitis, and bone illnesses in the United Kingdom, and Europe is predicted to increase at a CAGR of 3.0% from 2023 to 2033. In addition, government backing, together with increased research and development expenditure, is predicted to contribute significantly to market growth.
The high number of glucuronolactone producers in China and the high level of exports are expected to increase at a CAGR of 5.8% from 2023 to 2033. Furthermore, the product's widespread availability in China is projected to benefit the market in the approaching years. Also, the pharmaceutical industry in China, India, Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam is expanding.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Some of the key players operating in the glucuronolactone market are Shaoxing Marina Biotechnology Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Functional Food chem International Corporation, Merck Millipore Corporation, Jungbunzlauer, Shandong Fuyuan Bio-Tech CO.LTD, Roquette Frères, Shandong Xinhong Pharmaceutical Co., Ltd., Shandong Baisheng Biotechnology Co., Ltd., and others.
| Attributes | Details |
|---|---|
| Growth Rate | CAGR of 8.0% from 2023 to 2033 |
| Base Year of Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD million and Volume in Units and F-CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends and Pricing Analysis |
| Key Segments Covered | By Form, By End User, By Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, Italy, France, The United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia |
| Key Companies Profiled | Shaoxing Marina Biotechnology Co.Ltd.; Hubei Yitai Pharmaceutical Co.Ltd.; Merck Millipore Corporation; Anhui Fubore Pharmaceutical & Chemical Co.Ltd.; Functional Food chem International Corporation; Jungbunzlauer; Shandong Fuyuan Bio-Tech CO.LTD.; Roquette Frères; Shandong Xinhong Pharmaceutical Co., Ltd.; Shandong Baisheng Biotechnology Co., Ltd.; Ceto Coorporation; Creative Compound; Foodchem International; Merck Millipore |
| Customization & Pricing | Available upon Request |
The market is valued at USD 120.0 million in 2023.
Jungbunzlauer, and Roquette Frères are the prominent market players.
The market is likely to reach USD 256.2 million by 2033.
Rising awareness about a healthy lifestyle drives sales.
The market registered a CAGR of 5.4% from 2018 to 2022.
| Estimated Market Value (2024E) | USD 1.9 billion |
|---|---|
| Projected Market Revenue (2034F) | USD 3.3 billion |
| Value-based CAGR (2024 to 2034) | 5.2% |
| Market Size, 2023 | USD 20,795 million |
|---|---|
| Market Size, 2033 | USD 39,867 million |
| Value-based CAGR (2023 to 2033) | 6.7% |
Explore Functional Food Ingredients Insights
View Reports
Glucuronolactone Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
